• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BD Recalls Intraosseous Products Over Multiple Issues

    Rapid Medical Expands U.S. Portfolio

    MMS Holdings Partners With Lindsay Goldberg

    ENDRA Life Sciences Issued 28th Patent

    Levita Magnetics Closes $26M Series C
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Cirtec Medical

    Trademark Plastics Inc.

    JBC Technologies

    BMP Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    Cirtec Medical

    Trademark Plastics Inc.

    JBC Technologies

    BMP Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    3 Ways to Get High-Tech Devices to Market Quickly and Safely

    The FDA’s quest to modernize medical device reviews could require manufacturers to rethink their regulatory strategy in getting products through the agency.

    3 Ways to Get High-Tech Devices to Market Quickly and Safely
    Related CONTENT
    • AngioDynamics Receives FDA Approval to Initiate NanoKnife DIRECT Clinical Study
    • FDA Approves Device to Help Increase Access to More Lungs for Transplant
    • Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation
    • Fitbit and Solera Health Expand Partnership to Reduce Risk of Type 2 Diabetes
    • A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    Marc Helberg, Managing Vice President, Pariveda Solutions05.17.19
    During the 35-day partial government shutdown—the longest in United States history—we heard a lot about people ransacking national parks, the hundreds of thousands of struggling government workers, and bitter arguments around border wall funding. But one source of contention we didn’t hear as much about was pending U.S. Food and Drug Administration reviews.
     
    At the beginning of 2019, 52 healthcare-focused organizations penned an open letter stating the government shutdown placed medical innovation in peril. Several important new generic drugs, for instance, would take longer to reach market as a direct result of the shutdown.
     
    Their concern was fair, as the government’s drawn-out stall hampered important progress regarding research and review of medical products. Prior to the shutdown, the FDA had discussed incorporating big data and real-world evidence (RWE) into its review process.
     
    Modernizing Medical Device Oversight With RWE
    The FDA has good reason to incorporate RWE into these processes as well, as it would serve to improve trial efficiency and cost effectiveness. RWE is a data collection method where valid data is obtained outside the context of randomized controlled trials. It helps organizations make judgements that previously could only be made after extensive clinical trials, which are often expensive and challenging to administer.
     
    Rather than wait for trials to conclude and collect data only on participants, RWE encompasses real-life data from a broader spectrum of sources, including health insurance claims, electronic health records, registries, and personal medical devices. This provides a more comprehensive data set around patients, conditions, and innovative therapies.
     
    Tapping into big data and RWE can help the FDA more accurately gauge the impact new treatments and innovative medical devices could have. That’s because RWE provides data on a broader selection of the patient population and includes longer-term information on the effects of certain types of treatments—both of which should guide the development and review of all future healthcare solutions.
     
    How the FDA Will Move Forward
    Both manufacturers and the public are putting pressure on the FDA for fast, safe reviews. Late last year, the International Consortium of Investigative Journalists completed a yearlong investigation that pointed toward medical implants as a potential factor in 80,000 deaths since 2008. This called into question not just the safety of medical devices currently on the market, but also the robustness of FDA reviews.
     
    The FDA has since launched its Medical Device Safety Action Plan, which will ultimately seek to overhaul the process of reviewing medical devices before they hit the market. This also included the launch of the National Evaluation System for Health Technology (NEST). According to the FDA, NEST aims to “generate evidence across the total product lifecycle of medical devices by strategically and systematically leveraging real-world evidence and applying advanced analytics to data tailored to the unique data needs and innovation cycles of medical devices.”
     
    Until recently, manufacturers often sought quick clearance for their devices by claiming they were equivalent to ones previously cleared. The pathway for expedited clearance, known as a 510(k) clearance process, began in 1976. In some cases, new products and devices were cleared based on comparisons to old technology.
     
    Unsurprisingly, this led to claims that cleared devices weren’t vetted thoroughly enough, and manufacturers bore the brunt of that. Lawsuits against companies and products—such as those filed against pelvic mesh manufacturers—scare patients away, making it harder for them to receive effective treatment for their conditions.
     
    Achieving Faster, Safer Clearance
    This combination of shaky comparisons and limited clinical knowledge have created a system that’s no longer relevant in today’s healthcare market. A better one would include predicates based on current technology, greater levels of clinical trial activity, and plenty of RWE to verify product safety and effectiveness. As the FDA’s clearance system moves toward the future, medical device manufacturers should follow in kind.
     
    Following are three important factors for manufacturers to consider when working with new review systems.
     
    1. Continue pushing comparisons to newer technology
    Updating predicates is one of the most important goals of the FDA’s overhaul. According to Modern Healthcare, nearly 80 percent of devices on the market go through the 510(k) process, and almost 20 percent of those are cleared based on technology that’s at least a decade old. To quell this problem and increase trust, medical manufacturers should base their applications on up-to-date predicates.
     
    Overhauling the process will reduce the risks of new, fast-tracked products failing in the field and can lessen manufacturer vulnerability if a product does fail.
     
    2. Implement technology processes during research and development to fast-track new products
    As part of the push for newer predicates, the FDA recently created a specific fast-track for clearing technologies created by Apple, Samsung Electronics, Fitbit, and several other notable companies that manufacture wearables. The goal of the “Pre-Cert for Software Pilot,” as it’s called, is to help promote faster review of health-related technology products that meet a higher, more modern standard.
     
    These tech-first principles could be carried over to the medical device manufacturing side.
     
    3. Leverage artificial intelligence during diagnostics and R&D
    Using RWE in the R&D process is another significant step in overhauling the review process, especially when extensive clinical data isn’t available.
     
    More physicians, patients, and regulators accept RWE as a valid basis for decision-making, and using the right AI-based software during the R&D process can help manufacturers ensure their products align with the most relevant RWE data.
     
    Conclusion
    The FDA—along with its NEST and RWE initiatives—is meant to protect patient safety. Part of this involves streamlining evaluations for new medical devices. For the initiative to work and for manufacturers and patients to thrive under it, though, companies and regulatory agencies should work in tandem to modernize the review process.


    Marc Helberg is the managing vice president at the Philadelphia office of Pariveda Solutions, a consulting firm driven to create innovative, growth-oriented, and people-first solutions. (Click here to read more about the work Pariveda Solutions does.) He has extensive expertise delivering strategic initiatives and brings more than 25 years of consulting and industry experience to helping Fortune 100 companies transform their operating models and achieve their business goals. Outside of the office, he enjoys scuba diving, photography, cooking, and playing music.
     
    Related Searches
    • technologies
    • first
    • Manufacturing
    • it
    Suggested For You
    AngioDynamics Receives FDA Approval to Initiate NanoKnife DIRECT Clinical Study AngioDynamics Receives FDA Approval to Initiate NanoKnife DIRECT Clinical Study
    FDA Approves Device to Help Increase Access to More Lungs for Transplant FDA Approves Device to Help Increase Access to More Lungs for Transplant
    Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation
    Fitbit and Solera Health Expand Partnership to Reduce Risk of Type 2 Diabetes Fitbit and Solera Health Expand Partnership to Reduce Risk of Type 2 Diabetes
    A New, Tailored Review Framework for Artificial Intelligence-Based Devices A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    Cardiac Care on the Can Cardiac Care on the Can
    FDA to Modernize Mammography Services and Improve Their Quality FDA to Modernize Mammography Services and Improve Their Quality
    The Impact of mHealth on the Global Healthcare Fraternity The Impact of mHealth on the Global Healthcare Fraternity
    FDA Warns J&J and Sientra for Breast Implant Compliance Failure FDA Warns J&J and Sientra for Breast Implant Compliance Failure
    Study: Apple Watch May Help Flag Heart Rhythm Problems Study: Apple Watch May Help Flag Heart Rhythm Problems
    FDA to Closely Examine Surgical Stapler Risks FDA to Closely Examine Surgical Stapler Risks
    Sum and Substance: Material Considerations for Changing Design Needs Sum and Substance: Material Considerations for Changing Design Needs
    FDA Commissioner Scott Gottlieb to Step Down FDA Commissioner Scott Gottlieb to Step Down
    ICU Medical Recalls ChemoLock Vial Spike (20mm) Due to Risk of Detached Plastic Particles ICU Medical Recalls ChemoLock Vial Spike (20mm) Due to Risk of Detached Plastic Particles
    Shimmer Shimmer's Verisense Wearable Provides Biometric Data for Clinical Trials

    Related Breaking News

    • AngioDynamics Receives FDA Approval to Initiate NanoKnife DIRECT Clinical Study

      AngioDynamics Receives FDA Approval to Initiate NanoKnife DIRECT Clinical Study

      Study will examine the efficacy in the NanoKnife's treatment of Stage III pancreatic cancer.
      AngioDynamics Inc. 05.15.19

    • Surgical
      FDA Approves Device to Help Increase Access to More Lungs for Transplant

      FDA Approves Device to Help Increase Access to More Lungs for Transplant

      The Xvivo Perfusion System allows the transplant team to perform a more careful assessment of lung function.
      PR Newswire 04.30.19

    • Cardiovascular
      Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation

      Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation

      Stanford researchers presented preliminary findings from a virtual study that enrolled more than 400,000 participants.
      Business Wire 04.29.19


    • Fitbit and Solera Health Expand Partnership to Reduce Risk of Type 2 Diabetes

      Fitbit and Solera Health Expand Partnership to Reduce Risk of Type 2 Diabetes

      Solera network participants enrolled in diabetes prevention programs who used Fitbit devices had higher activity levels and increased weight loss.
      Business Wire 04.19.19

    • Digital Health | Software & IT
      A New, Tailored Review Framework for Artificial Intelligence-Based Devices

      A New, Tailored Review Framework for Artificial Intelligence-Based Devices

      The FDA is exploring a framework that would allow for modifications to algorithms to be made from real-world learning and adaptation.
      Scott Gottlieb, M.D. , Commissioner, U.S. Food and Drug Administration 04.03.19

    Loading, Please Wait..

    Trending
    • Cardinal Health CEO Mike Kaufmann Steps Down
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • TruArc Expands Medical Portfolio With Acquisition Of Molded Devices Inc.
    • Chronic, Infectious Disease Prevalence To Benefit Vital Signs Monitoring Market
    Breaking News
    • BD Recalls Intraosseous Products Over Multiple Issues
    • Rapid Medical Expands U.S. Portfolio
    • MMS Holdings Partners With Lindsay Goldberg
    • ENDRA Life Sciences Issued 28th Patent
    • Levita Magnetics Closes $26M Series C
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    Valspar Reveals Fresh Lineup of New Shades in 2023 Colors of the Year
    Evonik Grows Strongly in 1H 2022
    PPG Chairman and CEO Joins Disability:IN Effort to Advance Disability Inclusion
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BD Recalls Intraosseous Products Over Multiple Issues
    Rapid Medical Expands U.S. Portfolio
    MMS Holdings Partners With Lindsay Goldberg
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Invests $65M to Expand North American HQ
    Pace Appoints Nisheet Gupta as EVP and Chief Financial Officer
    West Pharmaceutical Makes Strategic Investment in Latch Medical
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    Hair Product Patented by L’Oréal
    Murad Unveils Supplement Product Lineup to Combat Acne, Aging
    R+Co Launches New Hairstyling Products
    Ink World

    Latest Breaking News From Ink World

    Flexible Packaging Market Expected to Reach $102.8 Billion by 2031: AMR
    Evonik Enjoys 31% Growth in 1H 2022
    Sun Chemical Returns to Labelexpo Americas 2022
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Colordyne hosts open house featuring hybrid print technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Surgalign, RTI Settle Lawsuit Over OEM Biz Sale
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login